First Time Loading...
C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 14.3 NOK -4.67% Market Closed
Updated: Apr 29, 2024

Wall Street
Price Targets

CARA Price Targets Summary
Carasent ASA

Wall Street analysts forecast CARA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CARA is 26.01 NOK with a low forecast of 25.25 NOK and a high forecast of 27.3 NOK.

Lowest
Price Target
25.25 NOK
77% Upside
Average
Price Target
26.01 NOK
82% Upside
Highest
Price Target
27.3 NOK
91% Upside
Carasent ASA Competitors:
Price Targets
EVH
Evolent Health Inc
65% Upside
GDRX
Goodrx Holdings Inc
24% Upside
FORA
Forian Inc
78% Upside
4483
JMDC Inc
83% Upside
KSI
Kneat.com Inc
18% Upside
PHF
Pharmagest Interactive SA
52% Upside
AUGX
Augmedix Inc
117% Upside
300253
Winning Health Technology Group Co Ltd
51% Upside

Revenue
Forecast

Revenue Estimate
Carasent ASA

For the last 8 years the compound annual growth rate for Carasent ASA's revenue is -2%. The projected CAGR for the next 3 years is 13%.

-2%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Carasent ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss

Net Income
Forecast

Net Income Estimate
Carasent ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CARA's stock price target?
Price Target
26.01 NOK

According to Wall Street analysts, the average 1-year price target for CARA is 26.01 NOK with a low forecast of 25.25 NOK and a high forecast of 27.3 NOK.

What is Carasent ASA's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Carasent ASA's revenue is -2%. The projected CAGR for the next 3 years is 13%.